Your browser doesn't support javascript.
loading
Potent and selective inhibitors of CDPK1 from T. gondii and C. parvum based on a 5-aminopyrazole-4-carboxamide scaffold.
Zhang, Zhongsheng; Ojo, Kayode K; Vidadala, Ramasubbarao; Huang, Wenlin; Geiger, Jennifer A; Scheele, Suzanne; Choi, Ryan; Reid, Molly C; Keyloun, Katelyn R; Rivas, Kasey; Siddaramaiah, Latha Kallur; Comess, Kenneth M; Robinson, Kenneth P; Merta, Philip J; Kifle, Lemma; Hol, Wim G J; Parsons, Marilyn; Merritt, Ethan A; Maly, Dustin J; Verlinde, Christophe L M J; Van Voorhis, Wesley C; Fan, Erkang.
Afiliación
  • Zhang Z; Department of Biochemistry, University of Washington, Seattle, WA 98195, United States.
  • Ojo KK; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
  • Vidadala R; Department of Chemistry, University of Washington, Seattle, WA 98195, United States.
  • Huang W; Department of Biochemistry, University of Washington, Seattle, WA 98195, United States.
  • Geiger JA; Seattle Biomedical Research Institute, Seattle, WA 98109, United States.
  • Scheele S; Seattle Biomedical Research Institute, Seattle, WA 98109, United States.
  • Choi R; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
  • Reid MC; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
  • Keyloun KR; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
  • Rivas K; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
  • Siddaramaiah LK; Department of Biochemistry, University of Washington, Seattle, WA 98195, United States.
  • Comess KM; High Throughput Biology, Global Pharmaceutical R&D, AbbVie, North Chicago, IL 60064, United States.
  • Robinson KP; High Throughput Biology, Global Pharmaceutical R&D, AbbVie, North Chicago, IL 60064, United States.
  • Merta PJ; High Throughput Biology, Global Pharmaceutical R&D, AbbVie, North Chicago, IL 60064, United States.
  • Kifle L; High Throughput Biology, Global Pharmaceutical R&D, AbbVie, North Chicago, IL 60064, United States.
  • Hol WG; Department of Biochemistry, University of Washington, Seattle, WA 98195, United States.
  • Parsons M; Seattle Biomedical Research Institute, Seattle, WA 98109, United States.
  • Merritt EA; Department of Biochemistry, University of Washington, Seattle, WA 98195, United States.
  • Maly DJ; Department of Chemistry, University of Washington, Seattle, WA 98195, United States.
  • Verlinde CL; Department of Biochemistry, University of Washington, Seattle, WA 98195, United States.
  • Van Voorhis WC; Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA 98195, United States.
  • Fan E; Department of Biochemistry, University of Washington, Seattle, WA 98195, United States.
ACS Med Chem Lett ; 5(1): 40-44, 2014 Jan 09.
Article en En | MEDLINE | ID: mdl-24494061
ABSTRACT
5-Aminopyrazole-4-carboxamide was used as an alternative scaffold to substitute for the pyrazolopyrimidine of a known "bumped kinase inhibitor" to create selective inhibitors of calcium-dependent protein kinase-1 from both Toxoplasma gondii and Cryptosporidium parvum. Compounds with low nanomolar inhibitory potencies against the target enzymes were obtained. The most selective inhibitors also exhibited submicromolar activities in T. gondii cell proliferation assays and were shown to be non-toxic to mammalian cells.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Med Chem Lett Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos
...